FDA Panel Likes Diabetes Drug on Second Try
(MedPage Today) -- An FDA advisory panel has voted 13-1 in favor of approval for dapagliflozin (Forxiga), a type 2 diabetes drug that the agency had turned down last year.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Heart